|
US7083983B2
(en)
|
1996-07-05 |
2006-08-01 |
Cancer Research Campaign Technology Limited |
Inhibitors of the interaction between P53 and MDM2
|
|
GB9708092D0
(en)
*
|
1997-04-22 |
1997-06-11 |
Univ Dundee |
Materials and methods relating to inhibiting the interaction of p53 and mdm2
|
|
EP0989136A4
(en)
*
|
1997-05-15 |
2002-10-09 |
Kyowa Hakko Kogyo Kk |
PEPTIDES WITH CYCLIC STRUCTURES THAT CAN RECOVER THE ACTIVITY OF MUTED P53 PROTEINS.
|
|
US6238921B1
(en)
*
|
1998-03-26 |
2001-05-29 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of human mdm2 expression
|
|
EP0947494A1
(en)
*
|
1998-03-30 |
1999-10-06 |
F. Hoffmann-La Roche Ag |
Derivatives of phenoxy acetic acid and phenoxymethyltetrazole having antitumor activity
|
|
WO1999061608A2
(en)
*
|
1998-05-26 |
1999-12-02 |
Institute Of Molecular And Cell Biology |
Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
|
|
GB9819860D0
(en)
*
|
1998-09-12 |
1998-11-04 |
Zeneca Ltd |
Chemical compounds
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
US20040038902A1
(en)
|
2000-04-05 |
2004-02-26 |
Pincus Matthew R. |
Peptides selectively lethal to malignant and transformed mammalian cells
|
|
AU2004212928A1
(en)
|
2003-02-13 |
2004-09-02 |
Bioveris Corporation |
Deazaflavin compounds and methods of use thereof
|
|
ES2586387T3
(es)
|
2003-11-05 |
2016-10-14 |
Dana-Farber Cancer Institute, Inc. |
Péptidos alfa helicoidales adecuados para activar o inhibir la muerte celular
|
|
WO2005097820A1
(en)
*
|
2004-04-06 |
2005-10-20 |
Korea Research Institute Of Bioscience And Biotechnology |
Peptides for inhibiting mdm2 function
|
|
DE602004024831D1
(de)
*
|
2004-04-22 |
2010-02-04 |
Ortho Mcneil Pharm Inc |
Hdm2-inhibitorkomplexe und verwendungen davon
|
|
DK2118123T3
(en)
|
2007-01-31 |
2016-01-25 |
Dana Farber Cancer Inst Inc |
Stabilized p53 peptides and uses thereof
|
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
US9175047B2
(en)
|
2009-01-14 |
2015-11-03 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CA2765657A1
(en)
*
|
2009-06-16 |
2010-12-23 |
Tokai University |
Anti-gram-negative bacteria agent
|
|
WO2011005219A1
(en)
*
|
2009-07-07 |
2011-01-13 |
Agency For Science, Technology And Research |
Novel mdm2 binding peptides and uses thereof
|
|
IN2012DN01693A
(https=)
|
2009-08-26 |
2015-06-05 |
Novartis Ag |
|
|
CN102712675A
(zh)
|
2009-09-22 |
2012-10-03 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
CU24130B1
(es)
|
2009-12-22 |
2015-09-29 |
Novartis Ag |
Isoquinolinonas y quinazolinonas sustituidas
|
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
|
ES2711526T3
(es)
|
2010-08-13 |
2019-05-06 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos
|
|
US8859586B2
(en)
|
2011-06-20 |
2014-10-14 |
Novartis Ag |
Cyclohexyl isoquinolinone compounds
|
|
WO2012175520A1
(en)
|
2011-06-20 |
2012-12-27 |
Novartis Ag |
Hydroxy substituted isoquinolinone derivatives
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
BR112014011137A2
(pt)
*
|
2011-11-09 |
2018-06-12 |
Merz Pharma Gmbh & Co Kgaa |
polinucleotídeo, vetor, célula hospedeira, polipeptídeo, anticorpo, método para a produção de um polipeptídeo, método para a produção de um medicamento
|
|
US9408885B2
(en)
*
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
BR112014020103A2
(pt)
|
2012-02-15 |
2018-10-09 |
Aileron Therapeutics, Inc. |
macrociclos peptidomiméticos
|
|
EP2819688A4
(en)
|
2012-02-15 |
2015-10-28 |
Aileron Therapeutics Inc |
TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
|
|
EP2855483B1
(en)
|
2012-05-24 |
2017-10-25 |
Novartis AG |
Pyrrolopyrrolidinone compounds
|
|
WO2014071241A1
(en)
|
2012-11-01 |
2014-05-08 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
|
US9556180B2
(en)
|
2013-01-22 |
2017-01-31 |
Novartis Ag |
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction
|
|
WO2014115077A1
(en)
|
2013-01-22 |
2014-07-31 |
Novartis Ag |
Substituted purinone compounds
|
|
EP3412675A1
(en)
|
2013-05-27 |
2018-12-12 |
Novartis AG |
Imidazopyrrolidinone derivatives and their use in the treatment of disease
|
|
AU2014272700B2
(en)
|
2013-05-28 |
2016-12-01 |
Novartis Ag |
Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
|
|
MX2015016421A
(es)
|
2013-05-28 |
2016-03-03 |
Novartis Ag |
Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades.
|
|
EA029269B1
(ru)
|
2013-11-21 |
2018-02-28 |
Новартис Аг |
Производные пирролопирролона и их применение для лечения заболеваний
|
|
AU2015320545C1
(en)
|
2014-09-24 |
2020-05-14 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and formulations thereof
|
|
EP3197478A4
(en)
|
2014-09-24 |
2018-05-30 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
WO2016154058A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2017044633A1
(en)
|
2015-09-10 |
2017-03-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of mcl-1
|
|
CN118436801A
(zh)
|
2016-05-20 |
2024-08-06 |
豪夫迈·罗氏有限公司 |
Protac抗体缀合物及其使用方法
|
|
EP3724216A1
(en)
|
2017-12-15 |
2020-10-21 |
Dana Farber Cancer Institute, Inc. |
Stabilized peptide-mediated targeted protein degradation
|
|
US11091522B2
(en)
|
2018-07-23 |
2021-08-17 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
CN109206474A
(zh)
*
|
2018-11-27 |
2019-01-15 |
青岛海洋生物医药研究院 |
一种线性肽合成方法
|
|
WO2020172115A1
(en)
*
|
2019-02-20 |
2020-08-27 |
Oncolyze, Inc. |
Hdm2 antibody for use in treating cancer
|
|
CN112266407B
(zh)
*
|
2020-09-28 |
2023-05-12 |
宁夏医科大学总医院 |
特异结合p53蛋白的七肽、编码基因、制备方法及用途
|
|
EP4312749A4
(en)
*
|
2021-03-31 |
2025-07-09 |
Zeteo Tech Inc |
DIAGNOSIS OF RESPIRATORY DISEASES BY CAPTURE OF AEROSOLIZED BIOMATERIAL PARTICLES USING FIXED BED SYSTEMS AND METHODS
|
|
WO2023056069A1
(en)
|
2021-09-30 |
2023-04-06 |
Angiex, Inc. |
Degrader-antibody conjugates and methods of using same
|
|
WO2024240858A1
(en)
|
2023-05-23 |
2024-11-28 |
Valerio Therapeutics |
Protac molecules directed against dna damage repair system and uses thereof
|